Comparison Between Two Techniques of Capsulotomy During Capsulorrhaphy in Cases of Developmental Dysplasia of the Hip
Launched by ASSIUT UNIVERSITY · May 30, 2024
Trial Information
Current as of October 30, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a randomized trial at Assiut University Hospital in Egypt that looks at two ways surgeons make an incision in the hip capsule during a common operation for Developmental Dysplasia of the Hip (DDH) in children. Specifically, it compares a U-shaped incision versus a T-shaped incision used during the capsulorrhaphy step (the part of the operation that helps keep the hip stable after the joint is reduced). The researchers will check which method leads to better hip function about one year after surgery, and also look at how long the operation takes, how many stitches are needed, and any problems such as the hip slipping out again, pain, or avascular necrosis. The trial is not finished yet.
Who may be eligible: children aged 1 to under 4 years with DDH, either one hip or both hips involved, who are planned for open reduction with capsulorrhaphy. Exclusions include kids younger than 1 or older than 4, or those with other conditions like neuromuscular disorders or a need for femoral shortening. Participants are randomly assigned to either the U-shaped or the T-shaped incision group, and the study is designed to follow them for about one year after surgery to compare outcomes. The study began enrolling in October 2023 and aims to finish around November 2025. Results are not available yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 1 year and younger than 4 years
- • Unilateral or bilateral cases
- Exclusion Criteria:
- • Patients younger than 1 year and older than 4 years old
- • Secondary hip dislocation ,neuromuscular disorders (as cerebral palsy, myelodysplasia or arthrogryposis).
- • Patients who will undergo femoral shortening.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported